Skip to main content
. 2012 Nov;12(11):969–978. doi: 10.1089/vbz.2012.0959

Table 2.

Unvaccinated and Locally-Bred Horses Positive for Antibodies to WNV, SLEV, ILHV, and FLAV

 
 
 
 
HIA titer
Epitope b-ELISA (%I)a
 
 
 
Sample ID Locality by town Gender Age group (y) WNV SLEV ILHV FLAV WNV SLEV WNV capture IgMb WNV PRNT titerc SLEV PRNT titerd
1C11H Chaguanas F 1–5 1:40 0 0 55.2 21.4 4.1 1.0 160 <20
1CH3H Chaguaramas M >10 0 0 0 39.0 36.4 1.6 NT NT NT
1O7H Wallerfield F 6–10 1:320 1:20 0 87.7 0 26.3 1.4 320 <20
1OR2H Wallerfield F Unknown 1:320 1:20 0 90.3 83 19.7 1.1 >640 <20
1P1H Petit Valley F 1–5 1:320 1:40 1:20 62.1 47.9 10.6 2.6 NT NT
1P3H Petit Valley F 6–10 1:320 1:40 1:40 73.7 43.2 29.5 1.2 NT NT
1S3H Santa Cruz M 1–5 1:2560 1:160 1:160 94.9 80.7 23.3 16.3 >640 160
1S4H Santa Cruz M 1–5 1:2560 1:80 1:40 93.5 86.9 23.3 2.7 >640 40
1S5H Santa Cruz M 1–5 1:1280 1:160 1:80 81.3 75.2 2.7 3.0 >640 40
3RT5H Arima F 1–5 1:40 0 0 43.7 0 29.4 1.1 160 <20
3RT19H Arima F 1–5 1:160 1:20 0 41.4 0 21.5 1.3 320 20
a

Interpretation for epitope-blocking ELISA: <30% inhibition (%I) is antibody-negative, and >30% inhibition is antibody-positive.

b

West Nile immunoglobulin type M capture ELISA interpretation: <2.0 is antibody-negative, 2.0–3.0 is equivocal, and >3.0 is antibody-positive.

c

Plaque reduction neutralization test (PRNT) for WNV (titers are expressed as the reciprocal of the serum dilution yielding 90% reduction in the number of plaques).

d

PRNT for SLEV (titers are expressed as the reciprocal of the serum dilution yielding 90% reduction in the number of plaques).

ELISA, enzyme-linked immunosorbent assay; HIA, hemagglutination inhibition assay; SLEV, St. Louis encephalitis virus; EEEV, eastern equine encephalitis virus; VEEV, Venezuelan equine encephalitis virus; WNV, West Nile virus; ILHV, Ilheus virus; NT, not tested.